FMW Media’s New to The Street TV announces broadcasting its
sponsored program business show
, airing on
Bloomberg TV, Saturday, August 20, 2022, at 6:30 PM ET.
New to The Street’s TV episode #376 will air the
following five (5) business interviews:
1). PetVivo Holdings, Inc.'s (NASDAQ: PETV)
(NASDAQ: PETVW) ($PETV) interview with Mr. John Lai,
CEO/President.
2). Tonix Pharmaceuticals, Inc.'s (NASDAQ:
TNXP) ($TNXP) interview with Dr. Seth Lederman, MD, and CEO.
3). Mikra Cellular Sciences' (a division of
Lifeist Wellness, Inc.) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS:
NXTTF) interview with Faraaz Jamal, CEO.
4). "Unstoppable Women Entrepreneurs
Segment" – Integrity Payment Processing, Inc.'s interview
with Livia Caudell, CEO.
5). Sekur Private Data, Ltd.’s (OTCQX: SWISF)
(CSE: SKUR) (FRA: GDT0) interview with Mr. Alain Ghiai, CEO.
Episode #376
New to The Street TV airs the interview at the
Nasdaq Marketplace studio with Lai, CEO / President, PetVivo
Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW)
($PETV). Talking with TV Host Jane King, John talks about PetVivo
Holdings, Inc., a biomedical device company that manufactures,
commercializes, and licenses innovative medical devices and
therapeutics for companion animals. John provides viewers his
corporate updates regarding PETV’s partnership with MWI Animal
Health, a leading animal health products and services distributor,
and Amerisource Bergen subsidiary. The relationship between PETV
and MWI Animal Health continues to mature, creating business
synergies. MWI Animal Health generates about $5B in revenues yearly
and has a seasoned sales and marketing staff. Their sales team now
markets PETV’s injectable patented Spryng with OsteoCushion
Technology that treats osteoarthritis and joint afflictions
for dogs, horses, and cats. A naturally derived product, Spryng
mimics collagen tissue that significantly improves animals’
afflicted joints. MWI’s success comes from educating their
veterinarian clients about their drug products, and now they are
rolling-out educational videos about Spryng. John says veterinarian
schools teach their doctors differently about treating animal
osteoarthritis. He feels confident that the videos and other
marketing materials can show Spryng successfully treating the
bone-on-bone root cause of the disease. Petvivocare.org is a
charitable organization at PETV which donates products to help
animal rescue organizations treat dogs, cats, horses, and other
animals suffering joint-related afflictions. Any animal care
organization can apply for assistance by providing reasons for
needing help. John is excited about business progress and looks
forward to returning to the show to share further updates. The
on-screen QR code is available during the show; download or visit
PetVivo Holdings, Inc. - https://petvivo.com/
and Spryng with OsteoCushion Technology -
https://www.sprynghealth.com/.
New to The Street’s TV Host Jane King welcomes
back Dr. Seth Lederman, MD, CEO at Tonix Pharmaceuticals, Inc.
(NASDAQ: TNXP) ($TNXP), a clinical-stage biopharmaceutical Company.
Talking from the Nasdaq Marketplace studio, Seth updates viewers
about the Company’s current operations. Monkeypox is a global
problem with over 17,000 cases outside of Africa, and Seth believes
that the infection rate doubles each week. The WHO (World Health
Organization) recently declared Monkeypox an international health
emergency. For about ten years, Tonix Pharmaceuticals continue with
the clinical development of the TNX-801 live vaccine to prevent
Monkeypox and Smallpox. The overwhelming majority of those affected
are men who have sex with men (“MSM”). Since Monkeypox is NOT an
STD (sexually transmitted disease), other population demographics
could catch the virus. Seth informs viewers about the Company’s
live virus vaccine they are developing to prevent COVID.
Unfortunately, current vaccines are not protective enough and have
limited durations. Tonix intends to have its COVID vaccine overcome
the current marketplace vaccine limitations. The Company opened its
new “Advanced Development Center” that will manufacture clinical
trial supplies for live virus vaccines for both COVID and
MonkeyPox. Even with economic short-coming caused by COVID
displacement, TNXP opened the new manufacturing center in about
1-year. The facility can respond to President Biden’s “American
Pandemic Preparedness Plan” (AP3), so Tonix can make, in 100-days,
new vaccines to prevent new pathogen infections. Tonix is committed
to improving the lives of patients by identifying, researching, and
developing promising therapies which have the potential to address
unmet needs. Dr. Lederman will come back on a future show with
further updates. The on-screen QR code is available during the
show; download or visit Tonix Pharmaceuticals, Inc. -
https://www.tonixpharma.com/.
New to The Street TV re-airs the interview with
Faraaz Jamal, CEO at Mikra Cellular Sciences ("Mikra"), a
biosciences and consumer wellness company that develops innovative
therapies for cellular health and a division of Lifeist Wellness,
Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF). Talking
in-studio at the Nasdaq Marketplace, Jamal explains to TV Host Jane
King the Company's uniquely formulated nutraceutical bio-active
compounds. The CELLF™ product, once ingested, absorbs the
mineral/nutrient compounds through the small intestines for
cellular uses. Jamal reveals to viewers that cellular health is the
key to wellness and the link between cellular activities and
overall health. The vitamin market contains misconceptions and
false claims about overall consumer wellness. Taking handfuls of
pills is not the solution. Most of the time, one's body does not
need certain compounds but requires other compounds. CELLF™ is a
butter-type consistency that delivers its nutrient-filled
combinations directly to the jejunum (mid-small intestine) and
distributes from blood plasma to cells. The product doesn't need
individual customization; it absorbs compounds on the cellular
levels based on what the individual's body needs. Jamal says that
due to the human stress from COVID-19 and other social and economic
events, people are looking for ways to become healthy; as such, the
growth in wellness-based products continues. The Company's recent
consumer survey revealed that most people have difficulty
maintaining personal health. All the cells and organs of the body
are Mikra's targets to help individuals increase the body's
cellular ability to recover from any form of stress and obtain a
complete wellness solution. The parent Company, Lifeist Wellness,
Inc., is a business incubator in the health wellness sector. It
provides Mikra with the business and manufacturing support
necessary to produce its bioactive consumer products. The on-screen
QR code is available during the show; download or visit Mikra
Cellular Sciences - https://wearemikra.com/. The interview
originally aired July 30, 2022.
New to The Street's airs the "Unstoppable
Women Entrepreneurs - Segment" interview with Livia
Caudell, CEO at Integrity Payment Processing,
Inc. ("Integrity"). In studio at the Nasdaq Marketplace, Livia
talks to TV Co-Hosts Jane King and Rhonda Swan about the Company's
business model. Integrity assists high-risk businesses like crypto,
nutraceuticals, CBD, cannabis, online gaming, and other industries
in getting them the best possible percentages when accepting credit
cards. Mostly these industries place payment tickets at more than
$2500; they are not your typical brick/mortar business. They need
unique solutions to ensure seamless transactions when accepting
debit/credit card payments. Livia is committed to assisting her
clients with the best possible solutions with the lowest possible
fees. Her most significant customers are in the cannabis industry,
where dispensaries need a safer alternative beyond cash. Taking
cards is a limited option for cannabis operators, and Integrity
Payment Processing offers them merchant services with several
merchant accounts. Many businesses who use Integrity's merchant
services see increases in their bottom lines from reduced cost and
sales increases from taking credit/debit cards as alternative
payment options beyond just cash. Without a merchant account, a
business cannot accept payments from a credit/debit card, and a
merchant account is a must in today's growing digital money
economy. Integrity Payments Processing, Inc. is a successful
woman-owned business helping businesses with merchant accounts. The
on-screen QR code is available during the show; download or visit
Integrity Payment Processing, Inc. -
https://www.integritypaymentprocessing.com/.
On the New to The Street TV show, Mr. Alain Ghiai,
CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR)
(FRA: GDT0) (Sekur®), returns as a guest. He gives TV Host Jane
King and viewers an overview of the successful Q2 corporate
financial fundamentals based on selling its Sekur® cybersecurity
products. With the persistent and increased hacking of personal
data and privacy breaches on individuals and businesses, Sekur is
getting new subscribers for its email, text, and other encrypted
platforms. Alain told viewers that sales increased over 1100% for
Q2 ending June 30, 2022, compared to Q2, 2021. And the revenue for
July 2022 looks the best for the Company, and the Company expects
the August 2022 revenue to exceed that of July 2022. The Company
has good cash-on-hand, no debt, and expects operational
profitability in Q1 2023. The Company is looking at a possible
Nasdaq up-listing, and they plan on financing to enable them to
acquire more users. Sekur expects higher revenues. SekurVPN
(Virtual Private Network), SekurMail App for Android, and
SekurMessenger mass use adoption by business and governmental
entities from its Latin American division are all currently or soon
to be available. The “Chat-by-Invite” feature is now in 61
countries, offering a secure SMS text platform to end-users. These
subscription services are growing the Company’s bottom-line
revenues. With no request for phone numbers, no open-source
platform, no shared servers, no 3rd party providers, never selling
or mining data, and a culture committed to privacy, Sekur Private
Data offers cybersecurity solutions for a reasonable monthly fee.
As an added protection to subscribers, Sekur operates its internet
platforms and security businesses under the country of
Switzerland’s very tough privacy laws. Viewers can try out the
SekurMail/SekurMessanger and “Chat-by-Invite” and other services
for a week free, and then become a subscriber using discount
PROMO Code: SEKUR15 for a 15% savings. The
on-screen QR code is available during the show; download or visit
Sekur Private Data, Ltd. – http://www.Sekur.com.
About PetVivo Holdings,
Inc. (NASDAQ: PETV) (NASDAQ:
PETVW) ($PETV):
PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ:
PETVW) ($PETV) is an emerging biomedical device company focused on
manufacturing, commercializing, and licensing innovative medical
devices and therapeutics for companion animals. The Company’s
strategy is to leverage human therapies for treating companion
animals cost-effectively and time-efficiently. A key component of
this strategy is the accelerated timeline to revenues for
veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for the treatment of
animals and people. A portfolio of nineteen patents protects the
Company’s biomaterials, products, production processes, and methods
of use. The Company’s lead product SPRYNG™ with
OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for the management of lameness and other
joint-related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale -
https://petvivo.com/.
About Tonix Pharmaceuticals Holding Corp.
(NASDAQ: TNXP) ($TNXP):
Tonix Pharmaceuticals Holding Corp. (NASDAQ:
TNXP) ($TNXP) is a clinical-stage biopharmaceutical company focused
on discovering, licensing, acquiring, and developing small
molecules and biologics to treat and prevent human disease and
alleviate suffering. Tonix’s portfolio comprises immunology, rare
disease, infectious disease, and central nervous system (CNS)
product candidates. Tonix’s immunology portfolio includes biologics
to address organ transplant rejection, autoimmunity, and cancer.
TNX-15001 is a humanized monoclonal antibody targeting CD40-ligand
in development to prevent allograft and xenograft rejection and
treat autoimmune diseases. A Phase 1 study of TNX-1500 is expected
to be initiated in the second half of 2022. Tonix’s rare disease
portfolio includes TNX-29002 for the treatment of Prader-Willi
syndrome. The FDA has granted TNX-2900 Orphan-Drug Designation.
Tonix’s infectious disease pipeline consists of a vaccine in
development to prevent smallpox and Monkeypox called TNX-8013,
next-generation vaccines to prevent COVID-19, and an antiviral to
treat COVID-19. Tonix’s lead vaccine candidates for COVID-19 are
TNX-1840 and TNX-18504, live virus vaccines based on Tonix’s
recombinant pox vaccine (RPV) platform. TNX-35005
(sangivamycin, i.v. solution) is a small molecule
antiviral drug to treat acute COVID-19 and is in the pre-IND stage
of development. TNX-102 SL, (cyclobenzaprine HCl sublingual
tablets) is a small molecule drug being developed to treat Long
COVID, a chronic post-acute COVID-19 condition. Tonix expects to
initiate a Phase 2 study in Long COVID in the second quarter of
2022. The Company’s CNS portfolio includes small molecules and
biologics to treat pain, neurologic, psychiatric and addiction
conditions. Tonix’s lead CNS candidate, TNX-102 SL, is in mid-Phase
3 development to manage fibromyalgia, with a new Phase 3 study
launched in the second quarter of 2022. Finally, TNX-13006 is a
biologic designed to treat cocaine intoxication that is expected to
start a Phase 2 trial in the second quarter of 2022
- https://www.tonixpharma.com. (1TNX-1500 is an
investigational new biologic at the pre-IND stage of development
and has not been approved for any indication.2TNX-2900 is an
investigational new drug at the pre-IND stage of development and
has not been approved for any indication.3TNX-801 is a live
horsepox virus vaccine for percutaneous administration in
development to protect against smallpox and Monkeypox. TNX-801 is
an investigational new biologic and has not been approved for any
indication.4TNX-1840 and TNX-1850 are live horsepox virus vaccines
for percutaneous administration, in development to protect against
COVID-19. TNX-1840 and TNX-1850 are designed to express the
SARS-CoV-2 spike protein from the omicron and BA.2 variants,
respectively. TNX-1840 and TNX-1850 are investigational new
biologics at the pre-IND stage of development and have not been
approved for any indication. 5TNX-3500 is an investigational new
drug at the pre-IND stage of development and has not been approved
for any indication.6TNX-1300 is an investigational new biologic and
has not been approved for any indication.)
About Mikra Cellular
Sciences:
Mikra Cellular Sciences ("Mikra"), a division of
Lifeist Wellness, Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS:
NXTTF), is a breakthrough Company seeking to unlock cellular
potential and maximize the health of humans. Mikra intends to
bridge the scientific gap between cellular health and consumer
wellness and focuses on one's health at the cellular level.
Human cells are responsible for the overall functionality of human
biology. Mikra continues to develop products that can enhance
cellular absorption of key and need minerals and nutrients to
improve health and wellness. CELLF™ product is clinically tested
and engineered to bring balance to the body and mind on a cellular
level - https://wearemikra.com/. Lifeist Wellness, Inc. (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF) is sitting at the forefront
of a post-pandemic wellness revolution, leveraging the advancements
in science and technology to build breakthrough companies that
transform human wellness. Its portfolio business units include
CannMart, a B2B wholesale distribution business that facilitates
recreational cannabis sales to Canadian provincial government
control boards; CannMart Labs, a BHO extraction facility for the
production of high margin cannabis 2.0 products;
the CannMart.com marketplace, which provides US customers
with access to hemp-derived CBD and smoking accessories; Australian
Vapes, the country's largest online retailer of vaporizers and
accessories; Findify, a leading AI-powered search and discovery
platform; and Mikra, a biosciences and consumer wellness company
seeking to develop innovative therapies for cellular health.
Information on Lifeist and its businesses - www.lifeist.com,
www.cannmart.com, www.australianvaporizers.com.au,
www.wearemikra.com, and email: ir@lifeist.com.
About Integrity Payment
Processing, Inc.:
Integrity Payment Processing, Inc. offers the
lowest rates and has 5-star customer service with 100% transparency
in prices/fees, no application fees, and no integration fees. They
understand that each customer has its own unique business and that
a standard merchant account is inadequate for their business
operations. The electronic payment industry is not a
one-solution-fits-all industry. Integrity Payment Processing, Inc.
works hard to understand its clients' unique payment processing
needs and customizes the best solutions for growth. Integrity
Payment Processing is the premier payment solutions company that
excels in tailoring solutions to the cannabis industry -
https://www.integritypaymentprocessing.com/.
About Sekur Private Data
Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0)
($SWISF):
Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) is a Cybersecurity and Internet privacy
provider of Swiss-hosted solutions for secure communications and
secure data management. The Company distributes encrypted emails,
secure messengers, secure communication tools, secure cloud-based
storage, disaster recovery, and document management products. The
Company sells and serves consumers, businesses, and governments
worldwide through approved wholesalers, distributors, and
telecommunications companies. Contact Sekur Private Data, Ltd. at
corporate@globexdatagroup.com or
visit https://www.sekurprivatedata.com and https://www.sekur.com.
About FMW Media:
FMW Media operates one of the longest-running US
and International sponsored and Syndicated Nielsen Rated
programming TV brands, "New to The Street" and its blockchain show
"Exploring The Block." Since 2009, these brands have run
biographical interview segment shows across major U.S. Television
networks. The paid-for-TV programming platforms can potentially
reach over 540 million homes in the US and international markets.
FMW's New to The Street / Newsmax TV broadcasting platform airs its
syndication on Sundays at 10 -11 AM ET. FMW is also one of the
nation's largest buyers of linear television, long and short-form
paid programming
- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.
Forward-Looking Statements
Disclaimer:
This press release contains forward-looking
statements within Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934. In
some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology.
However, not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at which such performance or results are
achieved. This press release should be considered in all filings of
the Companies contained in the Edgar Archives of the Securities and
Exchange Commission at www.sec.gov.
CONTACT:
FMW Media Contact:
Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
"New to The Street" Business Development Office
1-516-696-5900 Support@NewtoTheStreet.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/4c6e32fc-3edf-44dc-aff7-e862d75ec5d3
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Apr 2024 to May 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From May 2023 to May 2024